Home
Conditions
Urinary Bladder, Overactive

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

602 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00311376

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Royal Oak, Michigan, United States

Randwick, New South Wales, Australia

Innsbruck, Austria

Ghent, Belgium

View all 14 locations

View Trial Details

Completed

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

NCT01600404

Conditions: Central Nervous System Diseases, Cognition Disorders, Cognitive Dysfunction, +21 more
Locations: Swiss Paraplegic Centre Nottwil, Canton of Lucerne, Switzerland

View Trial Details

Completed

Toviaz Post Marketing Surveillance Study

NCT00879398

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Soo Urology Clinic Asan, Chungcheongnam-do, South Korea

Seo Kyung-Keun Urology Clinic Cheonan-si, Chungcheongnam-do, South Korea

Cheonan Medical Center Cheonan-Si, Chungcheongnam-do, South Korea

Seoul Urology Clinic Gongju, Chungcheongnam-do, South Korea

View all 82 locations

View Trial Details

Completed

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

NCT02570035

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Female Urogenital Diseases, +11 more
Locations: Site JP81013 Aichi, Japan

Site JP81014 Aichi, Japan

Site JP81005 Chiba, Japan

Site JP81006 Chiba, Japan

View all 28 locations

View Trial Details

Completed

Drug Use-Results Survey of Betanis Tablets in Japan

NCT01919047

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Chugoku, Japan

Chūbu, Japan

Hokkaido, Japan

Kansai, Japan

View Trial Details

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00461292

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Middlebury, Connecticut, United States

Rio de Janeiro, Brazil

Victoria, British Columbia, Canada

Salouël, France

View Trial Details

Completed

A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

NCT01476800

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Healthy Subjects, +10 more
Locations: MDS Pharma Services (US) Inc. Lincoln, Nebraska, United States

View Trial Details

Completed

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT01868516

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Simon-Williamson Clinic, P.C. Birmingham, Alabama, United States

Physician's Resource Group Dothan, Alabama, United States

Coastal Clinical Research, Inc. Mobile, Alabama, United States

Coastal Clinical Research, Inc Mobile, Alabama, United States

View all 125 locations

View Trial Details

Completed

Peripheral Electrical Stimulation for the Treatment of Overactive Bladder

NCT01783392

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Idiopathic Overactive Bladder, +9 more
Locations: Sheffield Teaching Hospitals NHS foundation Trust, Royal Hallamshire Hospital Sheffield, South Yorkshire, United Kingdom

View Trial Details

Completed

FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

NCT00921245

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations: Many Locations, South Africa

View Trial Details

Urinary Bladder, Overactive

Urinary Bladder, Overactive trial results

Related conditions